IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 66.15

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-18 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.65% 30% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.65% 30% F 39% F
Trailing 12 Months  
Capital Gain 4.88% 52% F 47% F
Dividend Return 1.47% 94% A 23% F
Total Return 6.35% 67% D+ 39% F
Trailing 5 Years  
Capital Gain 20.57% 48% F 61% D-
Dividend Return 8.63% 95% A 26% F
Total Return 29.20% 62% D 56% F
Average Annual (5 Year Horizon)  
Capital Gain 4.27% 48% F 48% F
Dividend Return 5.65% 57% F 45% F
Total Return 1.38% 100% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 15.38% 71% C- 66% D+
Risk Adjusted Return 36.73% 67% D+ 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike